HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,857 | -11.3% | 13,453 | -0.1% | 0.00% | – |
Q2 2023 | $15,622 | -14.6% | 13,467 | +11.2% | 0.00% | – |
Q1 2023 | $18,289 | -44.8% | 12,112 | -8.5% | 0.00% | – |
Q4 2022 | $33,105 | -31.0% | 13,242 | +16.7% | 0.00% | – |
Q3 2022 | $48,000 | +50.0% | 11,344 | -1.9% | 0.00% | – |
Q2 2022 | $32,000 | -67.7% | 11,562 | -33.3% | 0.00% | – |
Q1 2022 | $99,000 | -46.2% | 17,324 | -14.0% | 0.00% | – |
Q4 2021 | $184,000 | +44.9% | 20,146 | +70.2% | 0.00% | – |
Q3 2021 | $127,000 | -65.9% | 11,838 | -50.6% | 0.00% | -100.0% |
Q2 2021 | $372,000 | -2.1% | 23,968 | +2.4% | 0.00% | 0.0% |
Q1 2021 | $380,000 | -7.5% | 23,417 | +20.6% | 0.00% | -50.0% |
Q4 2020 | $411,000 | +158.5% | 19,415 | +80.7% | 0.00% | +100.0% |
Q3 2020 | $159,000 | -9.1% | 10,742 | -9.8% | 0.00% | 0.0% |
Q2 2020 | $175,000 | -34.7% | 11,910 | +4.5% | 0.00% | 0.0% |
Q4 2019 | $268,000 | +0.4% | 11,395 | +35.1% | 0.00% | -50.0% |
Q3 2018 | $267,000 | -18.1% | 8,432 | +0.3% | 0.00% | 0.0% |
Q2 2018 | $326,000 | – | 8,404 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |